These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice. Martínez-Águila A; Fonseca B; Pérez de Lara MJ; Pintor J J Pharmacol Exp Ther; 2016 May; 357(2):293-9. PubMed ID: 26941171 [TBL] [Abstract][Full Text] [Related]
9. Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits. Pintor J; Martin L; Pelaez T; Hoyle CH; Peral A Eur J Pharmacol; 2001 Mar; 416(3):251-4. PubMed ID: 11290376 [TBL] [Abstract][Full Text] [Related]
10. Changes in melatonin receptor expression in a murine model of glaucoma. Martínez-Águila A; Fonseca B; Pérez de Lara MJ; Miras-Portugal MT; Gómez-Villafuertes R; Carracedo G; Pintor J Mol Vis; 2020; 26():530-539. PubMed ID: 32818016 [TBL] [Abstract][Full Text] [Related]
11. Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes. Serle JB; Wang RF; Peterson WM; Plourde R; Yerxa BR J Glaucoma; 2004 Oct; 13(5):385-8. PubMed ID: 15354076 [TBL] [Abstract][Full Text] [Related]
12. 2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists. Zlotos DP; Attia MI; Julius J; Sethi S; Witt-Enderby PA J Med Chem; 2009 Feb; 52(3):826-33. PubMed ID: 19193160 [TBL] [Abstract][Full Text] [Related]
13. [Novel agonists of melatonin receptors as promising hypotensive and neuroprotective agents for therapy of glaucoma]. Chesnokova NB; Beznos OV; Lozinskaya NA; Volkova MS; Zaryanova EV; Zefirov NA; Grigoryev AV Biomed Khim; 2017 Jan; 63(1):75-80. PubMed ID: 28251954 [TBL] [Abstract][Full Text] [Related]
14. Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines. Tsotinis A; Vlachou M; Papahatjis DP; Calogeropoulou T; Nikas SP; Garratt PJ; Piccio V; Vonhoff S; Davidson K; Teh MT; Sugden D J Med Chem; 2006 Jun; 49(12):3509-19. PubMed ID: 16759094 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands. Bedini A; Spadoni G; Gatti G; Lucarini S; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Scaglione F J Med Chem; 2006 Dec; 49(25):7393-403. PubMed ID: 17149869 [TBL] [Abstract][Full Text] [Related]
16. Melatonin-enhanced hyperactivation of hamster sperm. Fujinoki M Reproduction; 2008 Nov; 136(5):533-41. PubMed ID: 18715981 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3. Ettaoussi M; Péres B; Klupsch F; Delagrange P; Boutin JA; Renard P; Caignard DH; Chavatte P; Berthelot P; Lesieur D; Yous S Bioorg Med Chem; 2008 May; 16(9):4954-62. PubMed ID: 18372181 [TBL] [Abstract][Full Text] [Related]